Clinical Trials Sponsored by Orsi Academy

Total 2748 results

Orsi Academy

Enrolling by invitation

PBP vs Traditional Training: the T-REC Trial (T-REC)

Educational Problems

Belgium
Orsi Academy

Completed

Orsi Surgical Skills E-learning Trial (OSSET)

Surgery | E-learning

Belgium
Stefano Puliatti

Completed

PBP Versus Halsted's Model: the PROVESA Trial (PROVESA)

Educational Problems

Belgium
Orasi Medical, Inc.

Unknown

A Study of Alzheimer's Disease Using Magnetoencephalography (MEG) and the Synchronous Neural Interaction™ Test

Alzheimer's Disease

United States
Orasi Medical, Inc.

Completed

Improved Diagnosis of Alzheimer's Disease Using Magnetoencephalography (MEG)

Alzheimer's Disease

United States
Orasi Medical, Inc.

Unknown

Acute Effect of Lorazepam on Brain Activity Measured by Magnetoencephalograpy (MEG) and Electroencephalography (EEG)

Healthy Subjects

United States
Orasi Medical, Inc.

Completed

Acute Effect of Three Neuroactive Drugs Measured by Magnetoencephalography (MEG), Electroencephalography (EEG) and the Synchronous Neural Interaction Test

Healthy

United States
OSI Pharmaceuticals

Completed

A Study of OSI-7904L Versus 5-FU/LV as Treatment in Patients With Biliary Tract Cancer

Locally Advanced or Metastatic Adenoca of the Biliary Tract

United States, Belgium, Germany, Poland, Romania, Switzerland
OSI Pharmaceuticals

Completed

Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors

Advanced Solid Tumors

United States
OSI Pharmaceuticals

Completed

A Study of OSI-7904L as Treatment in Patients With Head and Neck Cancer Who Have Failed First-Line Therapy

Locally Recurrent or Metastatic Cancer of the Head and Neck | Must Have Failed First-Line Therapy

United States
OSI Pharmaceuticals

Completed

Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer

Gastric Adenocarcinoma | Gastroesophageal Adenocarcinoma

United States, United Kingdom, Belgium
Orasi Medical, Inc.
Novartis

Unknown

Tinnitus Measured by MEG and Synchronous Neural Interaction™ Test: Template Development

Tinnitus

United States
GBR Academy

Active, not recruiting

Reinforced PTFE Meshes Versus Customized Titanium Meshes

Bone Loss | Soft Tissue Infections | Dental Implant Failed | Surgical Procedure, Unspecified | Bone Density | Surgical Wound Dehiscence

Italy
Premedix Academy

Enrolling by invitation

Score TO Predict SHOCK - STOP SHOCK

Acute Coronary Syndrome | Acute Myocardial Infarction | Cardiogenic Shock

Slovakia
GBR Academy

Completed

Three-dimensional Bone Regeneration Using Custom-made Meshes With and Without Collagen Membrane

Soft Tissue Infections | Surgical Procedure, Unspecified | Bone Density | Surgical Wound Dehiscence | Bone Loss in Jaw

Italy
ARDEC Academy

Completed

Tomographic and Histologic Assessment on the Influence of the Use of a Collagen Membrane to Protect the Antrostomy After Maxillary Sinus Floor Augmentation.

Alveolar Bone Loss | Alveolar Bone Resorption

Colombia
ARDEC Academy

Completed

Immediate Loading a Histological Study

Edentulous Alveolar Ridge

Colombia
ARDEC Academy

Completed

Bone Healing at Implants Installed in Sites Prepared Either With a Sonic Device or Drills

Alveolar Bone Loss

Colombia
ARDEC Academy

Completed

Bone Healing at Non-submerged Implants Installed With Different Insertion Torques.

Edentulous; Alveolar Process, Atrophy

Colombia
Premedix Academy

Recruiting

Atrial Fibrillation in Relationship to Plasma Biomarkers (AFISBIO II)

Atrial Fibrillation

Slovakia
Premedix Academy

Unknown

Atrial Fibrillation in Relationship to Sleep Quality and Plasma Biomarkers (AFISBIO)

Atrial Fibrillation

Slovakia
GBR Academy

Completed

Piezo-surgery Versus Conventional Drills

Bone Formation
GBR Academy

Completed

Non-resorbable Membranes Versus Titanium Meshes and Resorbable Membranes

Bone Loss | Soft Tissue Infections | Dental Implant | Surgical Procedure, Unspecified | Bone Density

Italy
Jarmo Oksi

Completed

COVID-19: Salvage TOcilizumab as a Rescue Measure (COVIDSTORM)

Covid19

Finland
Children's Hospital of Philadelphia
American Academy of Pediatrics; Academic Pediatric Association

Completed

IV Glucose for Dehydration Treatment

Dehydration

United States
Mayo Clinic
OSI Pharmaceuticals

Completed

Exisulind Versus Placebo After Surgical Removal of the Prostate

Prostatic Neoplasms

United States
International Piezosurgery Academy

Completed

Apico-coronal Position of Tissue-level Implants Bone Stability

Bone Atrophy, Alveolar

Italy
International Piezosurgery Academy

Completed

Soft Tissue Width and Abutment Height Influence Peri-implant Bone Resorption (i-RES)

Alveolar Bone Loss

Italy
Emory University
OSI Pharmaceuticals

Terminated

A Phase II Trial of OSI-906 and Sorafenib in Advanced Hepatocellular Cancer

Liver Cancer

United States
Ori Diagnostic Instruments LLC

Suspended

Calorie Balance Monitoring and Analysis of Body Composition and Hydration Status (PCMMS)

Body Composition | Energy Expenditure | Energy Metabolism | Body Fluids

United States
International Piezosurgery Academy

Completed

Trans-gingival or Subcrestal Short Implants Posterior Maxilla Bone Changes

Alveolar Bone Resorption

Italy
International Piezosurgery Academy

Completed

Bone Formation Maxillary Sinus Width

Alveolar Bone Resorption

Italy
International Piezosurgery Academy

Completed

Increase of Peri-implant Soft Tissues With Screw or Membrane (DERMA)

Alveolar Bone Loss

Italy
International Piezosurgery Academy

Completed

Wedge Implant Narrow Crests: Multi-center Clinical Study

Alveolar Bone Loss

Italy
Military Medical Academy

Recruiting

Is the NPWTi Better Than the Conventional NPWT

Postoperative Wound Infection Superficial Incisional | Postoperative Wound Infection Deep Incisional Surgical Site

Bulgaria
International Piezosurgery Academy

Withdrawn

All-on-Four Implants With Ultrasonic (Nobelsinus)

Bone Atrophy, Alveolar

Italy
International Piezosurgery Academy

Completed

Implant Insertion Torque and Primary Stability (TorqueISQ)

DENTAL IMPLANTATION

Italy
International Piezosurgery Academy

Completed

Effectiveness in Limiting the Need to Elevate the Maxillary Sinus (SO-GHI)

Alveolar Bone Loss

Italy
International Piezosurgery Academy

Completed

Conventional and Ultrasonic Implant Site Preparation (PI-DRI)

Bone Atrophy, Alveolar

Italy
Indiana University
OSI Pharmaceuticals

Completed

Pilot Study of Erlotinib for the Treatment of Patients With de Novo Acute Myeloid Leukemia

Leukemia, Myelomonocytic, Acute

United States
Northwestern University
OSI Pharmaceuticals

Withdrawn

Erlotinib for Treatment of Psoriasis

Psoriasis

United States
Emory University
OSI Pharmaceuticals

Withdrawn

A Phase I Study of OSI-906 in Combination With Pemetrexed in Advanced Solid Tumor Malignancies

Neoplasms | Cancer | Tumors

United States
Ersi Voskaridou

Completed

Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis

Osteoporosis | Thalassemia Major

Greece
University of Arkansas
OSI Pharmaceuticals

Terminated

Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy

Metastatic Breast Cancer

United States
OSI Pharmaceuticals

Terminated

Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma (PETEY)

Recurrent or Refractory Pediatric Ependymoma

United States, Canada, United Kingdom
OSI Pharmaceuticals

Terminated

Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205

Ependymoma

United States, Canada, United Kingdom
OSI Pharmaceuticals

Completed

A Pharmacokinetic Study of Erlotinib in Cancer Patients With Advanced Solid Tumors, With Adequate and Moderately Impaired Hepatic Function

Advanced Solid Tumors

United States, United Kingdom
NYU Langone Health
OSI Pharmaceuticals

Terminated

Topotecan With Erlotinib for Topotecan Pretreated Ovarian Cancer

Ovarian Cancer

United States
ori snapiri

Not yet recruiting

Corticosteroids as an Additional Treatment for Mastoiditis In Children (COSMIC)

Mastoiditis; Acute
University of Oklahoma
OSI Pharmaceuticals

Terminated

Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera (OSI-TAR-766)

Polycythemia Vera

United States

Clinical Trials Sponsored by Orsi Academy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations